Spectrum Pharmaceutical
Scope
Date
~
-
Bio & Pharma
Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico
South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...
Feb 24, 2023 (Gmt+09:00)
-
Bio & Pharma
US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle
Following its lawsuit against Daewoong Pharmaceutical, South Korea's Medytox Inc. is waging an all-out legal war against domestic counterpart Hugel ...
Feb 24, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Dongwon solo bidder for Boryung Biopharma estimated at $385 mn
South Korea’s leading seafood and logistics conglomerate Dongwon Group is seeking to buy local biopharmaceutical company Boryung Biopharma Co....
Feb 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
POSCO Int'l's pharmaceutical biz in Sudan attains No. 2 market ranking
A pharmaceutical company in Sudan set up by South Korea's POSCO International to find business opportunities in and make social contributions to the...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm holds sales meeting for marketing Cenobamate in US
On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanall Biopharma invests in Interon Labs for brain disease treatments
South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharmaceutical reports record-high revenue in 2022
South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus
Medytox Inc. said in a regulatory filing on Wednesday that it is selling off approximately 2.19 million shares of Evolus, Daewoong Pharmaceutical's ...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
DongKoo Bio signs MOU to move into SE Asian healthcare market
DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, th...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
CMG Pharma acquires animal nutrition company ING Medix
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, said on Monday that it is moving into the pet nutrition supplement market by acquirin...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Handok signs agreement with Microsoft Korea for digital transformation
South Korea's leading pharmaceutical company Handok Inc. said Tuesday that it has signed a memorandum of understanding (MOU) with Microsoft Korea to...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Private equity
BASF, ADM join race to buy Korean ceramide maker Solus Biotech
BASF SE, the world’s largest chemical producer, US food processing giant ADM Co. and two other global companies have joined the race to acquir...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korea's CMG Pharmaceutical opens animal medicine unit
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, on Monday announced the launch of an animal medicine unit and entry into the market f...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries
South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean Proteina gets offers from global pharmaceutical companies
Global pharmaceutical companies are expressing keen interest in the South Korean diagnostics company Proteina. Unlike companies that search for sp...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
Boryung holds Care-in-Space Challenge in US for space healthcare startups
South Korea's pharmaceutical company Boryeong said on Friday that it held the first "Care-in-Space Challenge" event, a new space healthcare startup ...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea approves Daewoong Pharmaceutical's diabetes drug
DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...
Dec 02, 2022 (Gmt+09:00)
-
Food & Beverage
Daesang Welllife forms joint venture with Sinopharm Group
Daesang Welllife on Thursday said it has concluded a memorandum of understanding (MOU) with China Sinopharm International, an affiliate of China's l...
Dec 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)